Aller au contenu
Toutes les missions
Veille marché · Himalayas-app Publiée il y a 2 mois

Regulatory Affairs CMC Associate II

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer.

Entreprise ory Affairs CMC Associate II Iovance Biotherapeutics aims to be the global leader in innovating
Mode innovating, developing and delivering tumor infiltrating lymphocyte

Résumé

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer.